Blame bad incentives for bad science
By Bethany Berkshire,
ScienceNews
| 10. 21. 2016
Most of us spend our careers trying to meet — and hopefully exceed — expectations. Scientists do too. But the requirements for success in a job in academic science don’t always line up with the best scientific methods. The net result? Bad science doesn’t just happen — it gets selected for.
What does it mean to be successful in science? A scientist gets a job and funding by publishing a lot of high-impact papers with novel findings. Those papers and findings beget awards and funding to do more science — and publish more papers. “The problem that we face is that the incentive system is focused almost entirely on getting research published, rather than on getting research right,” says Brian Nosek, a psychologist at the University of Virginia in Charlottesville.
This idea of success has become so ingrained that scientists are even introduced when they give talks by the number of papers they have published or the amount of grant funding they have, says Marc Edwards, a civil engineer at Virginia Polytechnic Institute and State University in Blacksburg.
But rewarding...
Related Articles
By David Jensen, The California Stem Cell Report | 12.11.2025
California’s stem cell and gene therapy agency today approved spending $207 million more on training and education, sidestepping the possibility of using the cash to directly support revolutionary research that has been slashed and endangered by the Trump administration.
Directors...
By Tina Stevens, CounterPunch | 12.11.2025
Silicon Valley and other high tech billionaires are investing millions in start-ups dedicated to creating genetically engineered (GE) babies, according to a recent Wall Street Journal (WSJ) report. AI mogul Sam Altman, cryptocurrency entrepreneur Brian Armstrong, venture capitalist Peter...
By Jonathan Matthews, GMWatch | 12.11.2025
In our first article in this series, we investigated the dark PR tactics that have accompanied Colossal Bioscience’s de-extinction disinformation campaign, in which transgenic cloned grey wolves have been showcased to the world as resurrected dire wolves – a...
By Frankie Fattorini, Pharmaceutical Technology | 12.02.2025
Próspera, a charter city on Roatán island in Honduras, hosts two biotechs working to combat ageing through gene therapy, as the organisation behind the city advertises its “flexible” regulatory jurisdiction to attract more developers.
In 2021, Minicircle set up a...